Loading
ABL Europe
  • Home
  • GMP manufacturing
  • Hosting services
    • Hosting services
    • Resident companies
  • About
    • Our team
    • About us
    • Our values
    • Our facilities
    • News & Events
      • News
      • Events
  • Careers
  • Contact
  • Search

July 6, 2016 : Accinov is delighted to announce the appointment of André Dupont as the new Chairman of its Board !

13 July 2016/0 Comments/in News /by Typhaine DEROBERT
Read more →

June 1, 2016: iDD Biotech is granted new patents in the USA and in China about its Fc optimized MABs anti-CD19 !

1 June 2016/0 Comments/in News /by Typhaine DEROBERT
Read more →

April 19, 2016: iDD Biotech announces milestone achievement in DR5 antibody collaboration with Genmab

21 April 2016/in News /by acciadmin
Read more →

April 5, 2016: Maat Pharma & Accinov sign a partnership agreement to manufacture investigational new drugs

5 April 2016/in News /by acciadmin
Read more →

March 22, 2016: MaaT Pharma announces €10 million fundraising

22 March 2016/in News /by acciadmin
Read more →

September 22, 2014: Accinov, the biomanufacturing center of Lyonbiopole, obtains the authorization to open a pharmaceutical site from the French Health authority (ANSM)

22 September 2014/0 Comments/in News /by acciadmin
Read more →
Page 3 of 3123

News & Events

  • November 19, 2018: ABL Expands GMP Viral Vector Manufacturing Capacity with State-of-the-Art Facility Acquisition in Lyon, France
  • June 20, 2018: ABL EUROPE,THE PURCHASER OF ACCINOV
  • February 2018: ABL Europe Enters into a Collaboration for the GMP Manufacture of Hookipa Biotech’s Heterologous Viral Vector Immunotherapy Platform
  • January 2018: SillaJen and ABL Europe Expand Strategic Manufacturing Collaboration for Oncolytic Virus Therapies
  • January 2018: ABL EUROPE’S GMP MANUFACTURING FACILITY FOR VIRAL VECTOR PRODUCTION: SARTORIUS STEDIM

ABL Europe

Headquarter
4 Rue Laurent Fries,
67400 Illkirch-Graffenstaden
Phone: +33 3 88 55 10 00

Lyon Site
317, avenue Jean Jaurès,
FRANCE - 69007 LYON
Phone: +33 (0)4 37 28 73 00

Subscribe to our newsletter

© Copyright ABL Europe 2018    -    credit: Viewbox

Follow us:

 
Scroll to top